Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effect of Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum

NCT05325099 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05325099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05325099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effect of Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
Lead sponsor
National Taiwan University Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 18, 2024
Completion date
May 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney disease